How much is SmithRx worth in 2026?

SmithRx has a current valuation of N/A based on their Early Stage VC (Series A2) round and secondary market data.

How much funding has SmithRx raised?

SmithRx has raised N/A in total funding across 1 funding rounds.

SmithRx

Other Healthcare Technology Systems

SmithRx valuation and funding history | Last updated: July 31, 2018 | 1 funding rounds

Current Valuation

N/A

As of July 31, 2018

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A2)

$5.5M

Last Funding

Jul 2018

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
July 31, 2018	Early Stage VC (Series A2)	$5.5M	N/A	-

Valuation Analysis

Current Valuation Metrics

SmithRx is currently valued at N/A as of July 31, 2018.

Track SmithRx Valuation Updates

Get notified when SmithRx raises new funding or valuation changes

Explore More Data

Detailed analysis for SmithRx

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock SmithRx's valuation history, funding rounds, and growth metrics.

No credit card required

What is SmithRx Worth in 2026?

SmithRx is a leading private company in the Other Healthcare Technology Systems sector. Track SmithRx's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How SmithRx Valuation is Determined

Private company valuations like SmithRx's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.